TY - JOUR
T1 - Associations between Carotid Artery Plaque Burden, Plaque Characteristics, and Cardiovascular Events
T2 - The ARIC Carotid Magnetic Resonance Imaging Study
AU - Brunner, Gerd
AU - Virani, Salim S.
AU - Sun, Wensheng
AU - Liu, Li
AU - Dodge, Rhiannon C.
AU - Nambi, Vijay
AU - Coresh, Josef
AU - Mosley, Thomas H.
AU - Sharrett, A. Richey
AU - Boerwinkle, Eric
AU - Ballantyne, Christie M.
AU - Wasserman, Bruce A.
N1 - Funding Information:
Communities (ARIC) study has been funded in whole or in part with federal funds from the National Heart, Lung, and Blood Institute, NIH, US Department of Health and Human Services (grants HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, and HHSN268201700004I) with the ARIC Carotid Magnetic Resonance Imaging substudy examination funded by grant U01HL075572-04.
Funding Information:
reports grants from the National Institutes of Health (NIH) and the American Heart Association during the conduct of the study. Dr Nambi reports grants from NIH during the conduct of the study; other support from Merck, Amgen, Siemens, and Roche; grants from Veterans Health Administration; and personal fees from DynaMed outside the submitted work. Dr Virani reports grants from US Department of Veterans Affairs, World Heart Federation, and Tahir and Jooma Family and other support from American College of Cardiology outside the submitted work. Dr Coresh reports grants from NIH during the conduct of the study. Dr Mosley reports grants from NIH during the conduct of the study. Dr Ballantyne reports grants from NIH during the conduct of the study; grants and personal fees from Abbott Diagnostics, Amgen, Esperion, Novartis, Regeneron, Roche Diagnostic, and Akcea; grants from NIH, American Heart Association, and American Diabetes Association; personal fees from AstraZeneca, Amarin, Matinas BioPharma, Pfizer, Sanofi-Synthelabo, Althera, Novo Nordisk, Denka Seiken, Gilead Sciences, Janssen, Corvidia, Arrowhead, and New Amsterdam, outside the submitted work. Dr Liu reports grants from NIH during the conduct of the study. Dr Boerwinkle reports grants from NIH during the conduct of the study. Dr Wasserman reports grants from NIH during the conduct of the study.
Publisher Copyright:
© 2021 American Medical Association. All rights reserved.
PY - 2021/1
Y1 - 2021/1
N2 - Importance: It remains unknown whether in an asymptomatic community-based cohort magnetic resonance imaging (MRI) measures of plaque characteristics are independently associated with incident cardiovascular disease (CVD) events when adjusted for carotid artery (CA) wall thickness, a measure of plaque burden. Objective: To assess associations of CA MRI plaque characteristics with incident CVD events. Design, Setting, and Participants: The Atherosclerosis Risk in Communities (ARIC) study is a prospective epidemiologic study of the incidence of CVD in 15792 adults of which 2066 women and men were enrolled in the ARIC Carotid MRI substudy. ARIC participants were enrolled from 1987 to 1989, and the substudy was conducted between January 2004 and December 2005. Analysis began January 2017 and ended August 2020. Exposures: Incident CVD events during a median (interquartile range [IQR]) follow-up time of 10.5 (8.1-10.9) years were assessed. Main Outcomes and Measures: Proportional hazards Cox analyses were performed to ascertain associations between MRI variables of CA plaque burden and plaque characteristics. Results: Of 15792 ARIC participants, 2066 were enrolled in the substudy, of whom 1256 (701 women [55.8%]) had complete data and were eligible for incident CVD analyses. Carotid artery plaques in participants with incident CVD events (172 [13.7%]) compared with those without (1084 [86.3%]) had a higher normalized wall index (median [IQR], 0.48 [0.36-0.62] vs 0.43 [0.34-0.55]; P =.001), maximum CA wall thickness (median [IQR], 2.22 [1.37-3.52] mm vs 1.96 [1.29-2.85] mm; P =.01), maximum CA stenosis (median [IQR], 5% [0%-22%] vs 0% [0%-13%]; P <.001), and when present, a larger lipid core volume (median [IQR], 0.05 [0.02-0.11] mL vs 0.03 [0.01-0.07] mL; P =.03), respectively. The presence of a lipid core was independently associated with incident CVD events when adjusted for traditional CVD risk factors and maximum CA wall thickness (hazard ratio, 2.48 [95% CI, 1.36-4.51]; P =.003), whereas the presence of calcification was not. The frequency of intraplaque hemorrhage presence in this population of individuals free of CVD at baseline who were not recruited for carotid stenosis was too small to draw any meaningful conclusions (intraplaque hemorrhage presence: 68 of 1256 participants [5.4%]). Carotid artery lumen area and maximum stenosis, which were overall low, were independently associated with incident CVD events when adjusted for traditional CVD risk factors, as anticipated. Conclusions and Relevance: The presence of a CA lipid core on MRI is associated with incident CVD events independent of maximum CA wall thickness in asymptomatic participants..
AB - Importance: It remains unknown whether in an asymptomatic community-based cohort magnetic resonance imaging (MRI) measures of plaque characteristics are independently associated with incident cardiovascular disease (CVD) events when adjusted for carotid artery (CA) wall thickness, a measure of plaque burden. Objective: To assess associations of CA MRI plaque characteristics with incident CVD events. Design, Setting, and Participants: The Atherosclerosis Risk in Communities (ARIC) study is a prospective epidemiologic study of the incidence of CVD in 15792 adults of which 2066 women and men were enrolled in the ARIC Carotid MRI substudy. ARIC participants were enrolled from 1987 to 1989, and the substudy was conducted between January 2004 and December 2005. Analysis began January 2017 and ended August 2020. Exposures: Incident CVD events during a median (interquartile range [IQR]) follow-up time of 10.5 (8.1-10.9) years were assessed. Main Outcomes and Measures: Proportional hazards Cox analyses were performed to ascertain associations between MRI variables of CA plaque burden and plaque characteristics. Results: Of 15792 ARIC participants, 2066 were enrolled in the substudy, of whom 1256 (701 women [55.8%]) had complete data and were eligible for incident CVD analyses. Carotid artery plaques in participants with incident CVD events (172 [13.7%]) compared with those without (1084 [86.3%]) had a higher normalized wall index (median [IQR], 0.48 [0.36-0.62] vs 0.43 [0.34-0.55]; P =.001), maximum CA wall thickness (median [IQR], 2.22 [1.37-3.52] mm vs 1.96 [1.29-2.85] mm; P =.01), maximum CA stenosis (median [IQR], 5% [0%-22%] vs 0% [0%-13%]; P <.001), and when present, a larger lipid core volume (median [IQR], 0.05 [0.02-0.11] mL vs 0.03 [0.01-0.07] mL; P =.03), respectively. The presence of a lipid core was independently associated with incident CVD events when adjusted for traditional CVD risk factors and maximum CA wall thickness (hazard ratio, 2.48 [95% CI, 1.36-4.51]; P =.003), whereas the presence of calcification was not. The frequency of intraplaque hemorrhage presence in this population of individuals free of CVD at baseline who were not recruited for carotid stenosis was too small to draw any meaningful conclusions (intraplaque hemorrhage presence: 68 of 1256 participants [5.4%]). Carotid artery lumen area and maximum stenosis, which were overall low, were independently associated with incident CVD events when adjusted for traditional CVD risk factors, as anticipated. Conclusions and Relevance: The presence of a CA lipid core on MRI is associated with incident CVD events independent of maximum CA wall thickness in asymptomatic participants..
UR - http://www.scopus.com/inward/record.url?scp=85096719257&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096719257&partnerID=8YFLogxK
U2 - 10.1001/jamacardio.2020.5573
DO - 10.1001/jamacardio.2020.5573
M3 - Article
C2 - 33206125
AN - SCOPUS:85096719257
SN - 2380-6583
VL - 6
SP - 79
EP - 86
JO - JAMA Cardiology
JF - JAMA Cardiology
IS - 1
ER -